ribavirin has been researched along with Hypermelanosis in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (37.50) | 29.6817 |
2010's | 10 (62.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anty, R; Cardot-Leccia, N; Lacour, JP; Ortonne, JP; Passeron, T; Pop, S; Tran, A; Trucchi, R; Tsilika, K | 1 |
Gómez, S; Marcoval, J; Martín, C; Notario, J | 1 |
Güneş, P; Yaşar, B; Yaşar, Ş | 1 |
Caturelli, E; Dell'Isola, S; Ghittoni, G; Ialungo, AM; Roselli, P; Starnini, G | 1 |
Amorosa, VK; Kovarik, CL; Lin, J; Lott, JP | 1 |
Itha, S; Radha Krishna, Y | 1 |
Corrêa, ME; de Moraes, PC; Mautoni, MC; Noce, CW; Thomaz, LA | 1 |
Chiu, MW; Farshidi, D | 1 |
Goksugur, N; Karabay, O; Ogutlu, A | 1 |
Chawla, YK; Dhiman, RK; Duseja, A; Ghosh, S | 1 |
Bachmeyer, C; Pellen, JC | 1 |
Debbiche, A; Fenniche, S; Kerkeni, N; Marrak, H; Mlika, RB; Mokhtar, I | 1 |
González Díaz, P; López Peláez, MV; Téllez Molina, MJ; Vergas García, J | 1 |
Akcan, Y; Kavak, A; Korkmaz, U | 1 |
Bergholz, U; Ferenci, P; Formann, E; Gurguta, C; Kauer, C; Steindl-Munda, P | 1 |
Arduino, RC; Barnett, BJ; Bull, L; Torres, HA | 1 |
1 review(s) available for ribavirin and Hypermelanosis
Article | Year |
---|---|
Tongue hyperpigmentation during PEG-interferon-alfa/ribavirin therapy in a non-Caucasian patient with chronic hepatitis C: a case report and review of the literature.
Topics: Adult; Antiviral Agents; Black People; Drug Eruptions; Hepatitis C, Chronic; Humans; Hyperpigmentation; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Tongue | 2013 |
1 trial(s) available for ribavirin and Hypermelanosis
Article | Year |
---|---|
Secondary hyperpigmentation during interferon alfa treatment for chronic hepatitis C virus infection.
Topics: Adult; Aged; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Hyperpigmentation; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Mucous Membrane; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Skin Pigmentation | 2013 |
14 other study(ies) available for ribavirin and Hypermelanosis
Article | Year |
---|---|
Oral hyperpigmentation associated with interferon-alpha and ribavirin therapy for hepatitis C virus infection.
Topics: Antiviral Agents; Female; Hepatitis C, Chronic; Humans; Hyperpigmentation; Interferon-alpha; Middle Aged; Mouth Diseases; Ribavirin | 2014 |
Face skin hyperpigmentation during pegylated interferon and ribavirin therapy.
Topics: Antiviral Agents; Biopsy; Drug Combinations; Drug Therapy, Combination; Face; Hepatitis C, Chronic; Humans; Hyperpigmentation; Injections, Subcutaneous; Interferon-alpha; Male; Melanocytes; Middle Aged; Ribavirin; Skin; Treatment Outcome | 2015 |
A surprising hyperpigmentation of the gums and tongue.
Topics: Adult; Antiviral Agents; Female; Gingival Diseases; Hepatitis C, Chronic; Humans; Hyperpigmentation; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Tongue Diseases | 2008 |
Iatrogenic hyperpigmentation in chronically infected hepatitis C patients treated with pegylated interferon and ribavirin.
Topics: Antiviral Agents; Hepatitis C, Chronic; Humans; Hyperpigmentation; Iatrogenic Disease; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2009 |
What caused this lingual hyperpigmentation in a patient with chronic hepatitis C?
Topics: Antiviral Agents; Hepatitis C, Chronic; Humans; Hyperpigmentation; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Tongue Diseases | 2010 |
Tongue hyperpigmentation resulting from peginterferon alfa and ribavirin combination therapy: a case report.
Topics: Aged; Antiviral Agents; Brazil; Diagnosis, Differential; Drug Combinations; Female; Hepatitis C; Humans; Hyperpigmentation; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Skin Pigmentation; Tongue Diseases | 2009 |
Lingual hyperpigmentation from pegylated interferon and ribavirin treatment of hepatitis C.
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C; Humans; Hyperpigmentation; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Tongue Diseases | 2010 |
Tongue hyperpigmentation during interferon therapy.
Topics: Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Hyperpigmentation; Interferon alpha-2; Interferon-alpha; Middle Aged; Recombinant Proteins; Ribavirin; Tongue Diseases | 2011 |
Tongue hyperpigmentation resulting from peginterferon alfa-2b and ribavirin treatment in a patient with chronic hepatitis C.
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Hyperpigmentation; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Tongue; Tongue Diseases | 2012 |
Tongue hyperpigmentation during hepatitis C treatment.
Topics: Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C; Humans; Hyperpigmentation; Interferon-alpha; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Tongue; Tongue Diseases | 2012 |
[Lingual hyperpigmentation in a patient with chronic infection].
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Hyperpigmentation; Interferons; Polyethylene Glycols; Pregnancy; Pregnancy Complications; Pregnancy Complications, Infectious; Ribavirin; Tongue Diseases | 2013 |
Hair repigmentation in a hepatitis C patient treated with interferon and ribavirin.
Topics: Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Hair; Hepatitis C, Chronic; Humans; Hyperpigmentation; Interferons; Male; Middle Aged; Ribavirin; Risk Assessment; Severity of Illness Index | 2005 |
Tongue and skin hyperpigmentation during PEG-interferon-alpha/ribavirin therapy in dark-skinned non-Caucasian patients with chronic hepatitis C.
Topics: Adult; Black People; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Hyperpigmentation; Interferon alpha-2; Interferon-alpha; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Assessment; Sampling Studies; Severity of Illness Index; Skin; Tongue | 2006 |
Tongue hyperpigmentation in a caucasian patient coinfected with HIV and hepatitis C during peginterferon alfa-2b and ribavirin therapy.
Topics: Antiviral Agents; Female; Hepatitis C, Chronic; HIV Infections; Humans; Hyperpigmentation; Interferon alpha-2; Interferon-alpha; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Tongue Diseases; White People | 2007 |